Mepolizumab for treating severe eosinophilic asthma

Supporting evidence

• Evaluation report

• Committee papers (PDF 5.55 MB)

  Published:

  03 February 2021

• Review decision

• Review decision – January 2020 (TA431)

• Decision paper – January 2020 (PDF 234 KB)

  Published:

  29 January 2020

• Stakeholder list – January 2020 (PDF 152 KB)

  Published:

  29 January 2020